(Q43974598)

English

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies

scientific article published in June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic squamous cell carcinoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

object named as

Jose Baselga

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2

object named as

Roy S Herbst

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Jan B Vermorken

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Nadia Amellal

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2710-2719

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of untreated head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-line treatment with docetaxel after failure of a platinum-based chemotherapy in squamous-cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of second-line therapy to modify survival in relapsed squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin as second line chemotherapy in advanced or recurrent squamous cell carcinoma of head and neck region.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23442

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23442

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43974598&oldid=2105194592"